Delivery Order SPE2DB24D1205-SPE2DB25FDAMG
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, issued by the Defense Logistics Agency (DLA) on August 12, 2025, awards AmerisourceBergen Drug Corp a $2,127.92 firm fixed-price contract for the delivery of Ferumoxytol 510 mg/17 ml vials. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 13, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a contract ceiling value of $10,059.24. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was made without set-aside restrictions, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials totaling $16,217.68 with completion by September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used in clinical settings, reflecting the pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.44, is a Firm Fixed Price delivery order for the supply of 4567887605 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,699.44 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 10, 2025, with completion expected by September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $2,262.01 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Feraheme 510 mg/17 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility...